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ABSTRACT
Mutations in the genes that code for type VI collagen can lead to collagenopathies (collagen VI 
myopathies), such as Bethlem myopathy (BTHLM1), which affect structural tissues like muscles 
and tendons. We present the case of a young female and her two relatives who were discovered 
to share the autosomal dominant COL6A3 mutation and whose presentation to the clinic varied 
from mild to severe. Type VI collagenopathies represent a clinically and genetically heterogeneous 
spectrum of disorders generally characterized by muscle weakness and joint contractures. We 
highlight the importance of examining close relatives whenever possible and documenting a 
pedigree prior to proceeding with further electromyography (EMG) and lab workup, which in-
cludes obtaining genetic testing in order to reach a unifying diagnosis. The proband (L.C.) report-
ed challenges with activities of daily living due to distal hand weakness, had significant findings 
on neuromuscular exam, and had abnormalities on needle EMG testing. Five of her relatives were 
reported to have weakness and trouble with day-to-day function. Her mother (M.C.) and mater-
nal grandfather (W.C.) were able to be examined in person and had the condition genetically 
confirmed.
KEYWORDS 
Bethlem myopathy, collagenopathy, COL6A3, weakness, genetics
Author affiliations are 








Bethlem myopathy (BTHLM1), Ullrich myopathy 
(UCMD1), Collagen VI (COL6), electromyography 
(EMG), nerve conduction study (NCS)
CASE REPORT
L.C. (the proband) was a 21-year-old female who 
presented to the neurology clinic with complaints 
of numbness and paresthesias in distal extremities, 
spasms in the calves, 4 years of progressive finger and 
ankle weakness, and 2 years of difficulty with finger 
contractures and losing her grip, making feeding 
difficult. She was a product of a nonconsanguineous 
marriage, with a history of hepatitis C and substance 
abuse. The patient’s sister was diagnosed with hepa-
titis C after a history of IV drug use with the proband’s 
now ex-boyfriend; subsequently, L.C. was tested and 
diagnosed with hepatitis C but has yet to receive 
treatment. L.C. reported normal educational progress 
with appropriate early childhood milestones and 
swallowing function. She denied autonomic symp-
toms, demonstrated no fragile hyper-extensible skin, 
and was not hypermobile in her joints but did report 
inability to whistle. Pertinent negatives include no 
ataxia, ptosis, or fatigable weakness. She was medi-
cally managed with gabapentin 800mg TID for pares-
thesias and baclofen for leg spasms that were discon-
tinued when she became pregnant. Relevant social 
history included being unemployed and a mother 
to a toddler. Physical examination was pertinent for 
weakness of neck flexion, eye closure, and cheek puff-
ing, significant finger contractures and lesser elbow, 
knee, and ankle contractures, and scapular winging. 
There was no grip or percussion myotonia. There was 
generalized weakness involving deltoids, biceps, and 
wrists sparing finger flexors, quadriceps, hamstrings, 
and plantar flexion muscles. She was unable to kneel 
down, perform a squat, or get up off the floor. Reflex-
es were intact. Temperature sensation, light touch, 
vibration, and proprioception were diminished distal 
to the mid-shins. She toe-walked due to ankle con-
tractures. Lab testing showed normal CPK, B12, TSH/ 
Free T4, glucose, and HbA1c. Vitamin D was insuffi-
cient at 26.5 ng/ml. Ankle foot orthotics (AFO) were 
prescribed which she chose not to utilize. Normal 
nerve conduction study (NCS) of the arms and legs 
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ruled out large fiber peripheral neuropathy. EMG 
(Figure 2) revealed a lack of myotonic discharges, but 
there were myopathic units in the left biceps brachii 
and tibialis anterior muscles. The patient declined 
a muscle biopsy. Invitae genetic testing revealed a 
mutation in the COL6A3 gene at c.6354+1G>A. She 
was referred for genetic counseling, but her insurance 
did not cover it.
The family tree (Figure 1) indicated multiple rela-
tives who had distal hand weakness including two 
(37-year-old M.C. and 57-year-old W. C.) who were 
affected in an autosomal dominant fashion who were 
able to be examined (shown in red in Figure 1). M.C., 
the proband’s mother, was a 37-year-old woman 
with a medical history of depression and smoking, 
who was invited for saliva genetic testing and found 
to carry the same mutation as L.C. In the clinic, she 
complained of paresthesias in distal extremities and 
reported having had multiple tendon and Achilles 
lengthening surgeries. She took Lyrica and Neuron-
tin in the past. Pertinent exam findings were ham-
mertoes, high arches, areflexia at the ankles, and 
mild weakness of finger abduction and extension. 
NCS/EMG study showed a right common peroneal 
mononeuropathy with acute and chronic denerva-
tion in the right tibialis anterior and extensor hallucis 
longus. She was more mildly affected than L.C., as 
she felt well enough to not medicate her paresthesias 
and was not limited in her activities of daily living. 
W.C., the proband’s maternal 57-year-old grandfa-
ther, presented to the clinic in need of evaluation 
for disability benefits due to inability to work as a 
maintenance worker. His medical history included 
smoking, hypertension, and gastritis. He reported 
being slower to walk and run than his peers. In the 
last 10 years, he deteriorated and developed more 
cramps and an inability to climb stairs. Examination 
showed weakness of multiple muscle groups: bi-
ceps and triceps in the arms, finger extensors, finger 
FIGURE 1. Family pedigree. The arrow indicates the proband, L.C. The asterisk indicates other affected individuals 
with distal weakness and/or tendon surgery who were not genetically tested. The red color indicates individuals 
with a confirmed COL6A3 mutation (c.6354+1G>A).
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Figure 2. Table of nerve conduction results for the proband L.C.  showed that nerve conduction study results were entirely normal in 
all four extremities, which rules out any mononeuropathy or polyneuropathy.  (The electromyography data records for the proband 
L.C. could not be uploaded due to technical difficulties with resolution but are available upon request by contacting the correspond-
ing author. The needling of her four extremities was significant for early recruitment, short duration, and small amplitude units in the 
left biceps brachii and left tibialis anterior muscles,  which indicates myopathic changes that can occur in various muscle diseases but 
excludes diseases of nerve roots or motor neuron disease.)
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flexors, thumb abductors, knee contractions causing 
knee extension weakness, quadriceps weakness with 
difficulty arising from a chair, and ankle dorsiflexion 
weakness with steppage gait. Reflexes were intact 
except absent at the ankles. Pinprick sensation was 
normal. His labs showed A1c 5.6%, LDL 152, CK 454, 
and a negative celiac panel. Ankle foot orthotics were 
prescribed for him. W.C. submitted a blood sample 
for an Invitae collagenopathy panel, and the same 
pathogenic variant was found as in L.C. and M.C. It af-
fected a donor splice site in intron 19 of the COL6A3 
gene and disrupted RNA splicing, likely resulting in 
absent or disrupted protein. 
The finding of a c.6354+1G>A mutation in these 
relatives was previously reported in other individuals 
with Bethlem myopathy. Splice site variants typically 
lead to loss of protein function. This variant was not 
present in population databases (ExAC no frequen-
cy), but ClinVar contained an entry for this variant. 
The proband’s twin, younger sister, and maternal 
aunt who were all affected to variable degrees were 
not available to be tested genetically or examined 
in person. According to L.C., M.C., and W.C.’s recollec-
tion, the proband’s maternal great aunt suffered from 
many contractures and needed tendon surgeries. The 
proband’s twin sister and her 15-year-old sister (who 
also had tendon transfers) were both affected with 
similar distal hand weakness. 
DISCUSSION
The family pedigree (Figure 1) obtained in the clinic 
showed an autosomal dominant inheritance pattern 
over three generations. The proband’s history, exam, 
and EMG suggested a presumably neuromuscular 
disease localized to the distal skeletal muscles. Colla-
gen VI is a ubiquitously expressed microfibrillar pro-
tein found in skeletal muscles; when mutant ColVI-
null mice deficient in it were studied, they exhibited 
myopathic features including decreased muscle 
mass and contractile force.1 Contractures of Achilles 
tendons, which were repaired surgically in members 
of L.C.’s family, are a feature commonly described 
in Bethlem myopathy cases. Collagen VI has many 
other roles in the body including inhibition of apop-
tosis and oxidative damage, the promotion of tumor 
growth, and the regulation of cell differentiation and 
the autophagic machinery.2 Informed consent was 
obtained, and genetic counseling was recommended 
to discuss the implications of these results because 
they may affect subsequent offspring and close rela-
tives, especially those of child-bearing age. 
L.C.’s paresthesias were presumed to be from a hep-
atitis C-related small fiber neuropathy, but this was 
not confirmed with a skin biopsy. Alternate inves-
tigations described in the literature in similar cases 
include muscle biopsy to check for increased con-
nective tissue and fatty replacement with or without 
fiber necrosis, MRI imaging that shows concentric 
patterns in vastus lateralis and central high signal in 
rectus femoris, and Collagen VI Immunolabeling on 
cultured skin fibroblasts.3 These methods were not 
pursued due to the reliability of genetic testing. The 
three individuals presented here greatly benefited 
from pursuing a definitive genetic diagnosis because 
it gave them access to necessary resources such 
as genetic counseling and encouraged autonomy 
through family planning. Proactively, the proband 
chose to have her daughter examined by a pediatric 
neurologist at Nationwide Children’s Hospital. It is 
possible that L.C.’s daughter will need special class-
room accommodations, and she may possibly need 
an individualized education program. L.C. expressed 
an interest in having more children and that this 
spurred her to seek neurologic consultation. W.C. 
was able to get economic assistance by applying his 
specific diagnosis to the disability application.
The COL6A3 gene is associated not only with auto-
somal dominant and recessive Bethlem myopathy 
1 (BTHLM1) but with Ullrich congenital muscular 
dystrophy 1 (UCMD1). The phenotype associated 
with UCMD1 is typically toward the more severe end 
of the spectrum and is characterized by congeni-
tal muscle weakness, proximal joint contractures, 
and significant hyperlaxity of distal joints. BTHLM1 
patients experience progressive muscle weakness 
and joint stiffness (contractures) in their fingers, 
wrists, elbows, and ankles. During childhood, a 
developmental delay may be noted, however, the 
L.C. family cohort did not report lagging behind in 
education. By the age of 50-years-old, approximately 
two-thirds (66%) of people with BTHLM1 will need to 
use a walker, cane, or wheelchair. Some people with 
Bethlem myopathy have skin abnormalities such 
as follicular hyperkeratosis, but this was not seen in 
the individuals presented here. Rarely, individuals 
with BTHLM1 may develop breathing problems as 
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the disease progresses. Age of onset varies from the 
prenatal period to adulthood. Close relatives have 
up to a 50% chance of being a carrier. This condition 
has a differential diagnosis consisting of other rare 
diseases including congenital myopathies, facios-
capulohumeral muscular dystrophy, Emery-Dreifuss 
muscular dystrophy, limb-girdle muscular dystrophy, 
and Ehlers-Danlos connective tissue syndrome,4 
indicating the benefit of genetic testing. A targeted 
genetic test can offer cost-effective, safe, and fairly 
rapid turnaround time, which can improve the quali-
ty of care for patients.5
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